Key points from article :
Neko Health, the Swedish healthtech company co-founded by Spotify's Daniel Ek and Hjalmar Nilsonne, has raised an impressive $260 million in Series B funding to advance its preventive health technology and expand globally. The funding will support Neko's plans to scale its non-invasive full-body scanning services across Europe and the United States while investing in groundbreaking research and development for early disease detection.
Neko Health’s innovative £299 health scan captures millions of data points in under an hour, assessing risks for conditions such as skin cancer, cardiovascular disease, metabolic disorders, and more. Patients receive immediate results during a doctor-led consultation, empowering them to take control of their health. In its first year, the company analysed 2,707 scans, revealing that 14.1% of participants required medical intervention, with 1% benefiting from potentially life-saving interventions.
The service has already gained significant traction, completing 10,000 scans in London and Stockholm, with 76% of users opting to rebook. With a waiting list of over 100,000 people, demand is surging. According to CEO Nilsonne, Neko Health aims to transform healthcare from a reactive system to a proactive one, emphasizing wellness over illness.
The funding round, led by Lightspeed Venture Partners with contributions from major investors like General Catalyst and Atomico, reflects confidence in Neko's vision. Lightspeed’s Bejul Somaia, now on Neko’s board, praised the company’s innovative approach to preventive care, highlighting its potential to make proactive healthcare accessible and scalable globally.
